Literature DB >> 33091686

Aberrant functional connectivity between the suprachiasmatic nucleus and the superior temporal gyrus: Bridging RORA gene polymorphism with diurnal mood variation in major depressive disorder.

Zhilu Chen1, Shiwan Tao1, Rongxin Zhu1, Shui Tian2, Yurong Sun2, Huan Wang2, Rui Yan3, Junneng Shao2, Yujie Zhang2, Jie Zhang1, Zhijian Yao4, Qing Lu5.   

Abstract

Diurnal mood variation (DMV), a common symptom of major depressive disorder (MDD), is associated with circadian related genes and dysregulation of the suprachiasmatic nucleus (SCN). Previous research confirmed that the RORA gene is involved in the regulation of circadian rhythms. In this study, we hypothesized that polymorphisms of RORA may affect DMV symptoms of MDD through functional changes in the SCN. A total of 208 patients diagnosed with depression and 120 control subjects were enrolled and underwent a resting-state functional magnetic resonance imaging (rs-fMRI). Blood samples were collected and genotyping of 9 RORA gene SNPs were performed using next-generation sequencing technology. Patients were categorized as an AA genotype or C allele carriers based on RORA rs72752802 polymorphism. SCN-seed functional connectivity (FC) was compared between the two groups and correlation with severity of DMV was analyzed. Finally, a mediation analysis was performed to further determine FC intermediary effects. We observed that rs72752802 was significantly associated with patients' DMV symptoms. C allele carriers of rs72752802 showed significantly decreased FC between the right SCN and right superior temporal gyrus (rSTG). This was also correlated with DMV symptoms. In addition, the rs72752802 SNP influenced DMV symptoms through intermediary effects of SCN-rSTG connectivity. The study presented here provides a neurological and genetic basis for understanding depressed patients experiencing DMV.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Circadian rhythm; Diurnal mood variation; Functional connectivity; Major depressive disorder; Resting-state functional magnetic resonance imaging; Retinoic acid related orphan receptor alpha

Mesh:

Substances:

Year:  2020        PMID: 33091686     DOI: 10.1016/j.jpsychires.2020.09.037

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  3 in total

1.  General Transcription Factor IIF Polypeptide 2: A Novel Therapeutic Target for Depression Identified Using an Integrated Bioinformatic Analysis.

Authors:  Chi Zhang; Min Cheng; Naifu Dong; Dongjie Sun; Haichun Ma
Journal:  Front Aging Neurosci       Date:  2022-05-27       Impact factor: 5.702

2.  The Suprachiasmatic Nucleus Regulates Anxiety-Like Behavior in Mice.

Authors:  Chelsea A Vadnie; Kaitlyn A Petersen; Lauren A Eberhardt; Mariah A Hildebrand; Allison J Cerwensky; Hui Zhang; Jennifer N Burns; Darius D Becker-Krail; Lauren M DePoy; Ryan W Logan; Colleen A McClung
Journal:  Front Neurosci       Date:  2022-01-20       Impact factor: 4.677

3.  Building a model for predicting metabolic syndrome using artificial intelligence based on an investigation of whole-genome sequencing.

Authors:  Nai-Wei Hsu; Kai-Chen Chou; Chien-Feng Kuo; Yu-Ting Tina Wang; Chung-Lieh Hung; Shin-Yi Tsai
Journal:  J Transl Med       Date:  2022-04-28       Impact factor: 8.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.